Long term pharmacotherapy for obesity and overweight: updated meta-analysis

2007795 citationsReviewbronze Open Access

Authors

Cíntia Chaves Curioni · University of Alberta

David C.W. Lau · Faculdade de Medicina de Petrópolis

Abstract

Orlistat, sibutramine, and rimonabant modestly reduce weight, have differing effects on cardiovascular risk profiles, and have specific adverse effects.

Topics & Keywords

Pharmacology and Obesity Treatment Diabetes Treatment and Management Muscle metabolism and nutrition

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMJ

Volume 335, Issue 7631, pp. 1194-1199

DOI: 10.1136/bmj.39385.413113.25

Field-Weighted Citation Impact: 56.41